|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
BAX
|
Baxter International Inc.
|
US
|
NYSE
|
|
CBIO
|
Catalyst Inc.
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
US
|
NASDAQ
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
US
|
NASDAQ
|
|
SGTX
|
Sigilon Therapeutics, Inc.
|
US
|
NASDAQ
|
|
SEOVF
|
Sernova Corp
|
US
|
OTC
|
|
38I
|
Intellia Therapeutics Inc
|
DE
|
F
|
|
006280
|
Green Cross Corp
|
KR
|
KO
|
|
260
|
CENTESSA PHARMACEUTICALS
|
DE
|
F
|
|
2RZ
|
POSEIDA THERAP. DL-0001
|
DE
|
F
|
|
G0F
|
GRIFOLS ADR 1/2/EO-50
|
DE
|
F
|
|
G0FB
|
Grifols S.A
|
DE
|
F
|
|
OZTA
|
Grifols S.A
|
DE
|
F
|
|
0RDU
|
Grifols S.A.
|
GB
|
LSE
|
|
GRF
|
Grifols S.A.
|
ES
|
MC
|